Alana T Brennan, PhD

Publications

• Published on 12/1/2025

  Dzomba A, Shumba K, Nattey C, Lauren E, Brennan AT, McLoed W, Fox MP, Bor J, Onoya D. HIV Patient Treatment Adherence Trajectories in First 24 months After ART Initiation Among Adults: An Electronic Health Records Cohort From South Africa. J Acquir Immune Defic Syndr. 2025 Dec 01; 100(4):305-314. PMID: 40778758.

  Read At: PubMed

• Published on 9/22/2025

  Zheng A, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Murray EJ, Pisa PT, Goeieman B, Fox MP, Maskew M. Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation. Infect Dis (Lond). 2025 Sep 22; 1-11. PMID: 40982349.

  Read At: PubMed

• Published on 9/1/2025

  Zheng A, Kileel EM, Brennan AT, Flynn DB, Rosen S, Fox MP. Systematic review and meta-analysis of retention and disengagement after initiation on antiretroviral therapy in low- and middle-income countries after the introduction of Universal Test and Treat policies. J Int AIDS Soc. 2025 Sep; 28(9):e70026. PMID: 40908808.

  Read At: PubMed

• Published on 7/31/2025

  Valiente R, Tunstall H, Kong AY, Wilson LB, Gillespie D, Angus C, Brennan A, Shortt NK, Pearce J. Geographical differences in the financial impacts of different forms of tobacco licence fees on small retailers in Scotland. Tob Control. 2025 Jul 31; 34(4):461-471. PMID: 38326025.

  Read At: PubMed

• Published on 6/17/2025

  Degeling K, Karnon J, van de Ven M, Brennan A, Koffijberg H. Discrete Event Simulation in R using the 'Simmer' Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer. Appl Health Econ Health Policy. 2025 Nov; 23(6):961-975. PMID: 40528145.

  Read At: PubMed

• Published on 6/1/2025

  Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Brennan AT, Maskew M. Initiation of Dolutegravir Versus Efavirenz on Viral Suppression and Retention at 6 months: A Regression Discontinuity Design. J Acquir Immune Defic Syndr. 2025 Jun 01; 99(2):151-157. PMID: 39913899.

  Read At: PubMed

• Published on 4/5/2025

  Onuwe T, Highton PJ, Batchelor D, Brennan A, Caba M, Davies MJ, Funnell MP, Game F, Gillies CL, Glab A, Gray LJ, Gregg E, Hadjiconstantinou M, Hall V, Johnson V, Petrie JR, Pollard D, Rowntree H, Tesfaye S, Valabhji J, Webb D, Zaccardi F, Khunti K. A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi-centre randomised control trial (MiFoot study). Diabet Med. 2025 Jun; 42(6):e70028. PMID: 40186438.

  Read At: PubMed

• Published on 3/22/2025

  Jones RA, Mueller J, Richards R, Woolston J, Stubbings M, Whittle F, Hill AJ, Hughes CA, Duschinsky R, Sharp SJ, Chester M, Schwertel C, Tait S, Eustachio Colombo P, Kudlek L, Boothby CE, Bostock J, Breeze P, Brennan A, Fusco F, Lawlor ER, Morris S, Griffin SJ, Ahern AL. An Acceptance-Based Guided Self-Help Program for Weight Loss Maintenance in Adults Who Have Previously Completed a Behavioral Weight Loss Program: The SWiM Feasibility Study. Obes Sci Pract. 2025 Apr; 11(2):e70048. PMID: 40124957.

  Read At: PubMed

• Published on 1/6/2025

  Chabala FW, Siew ED, Wester CW, Brennan AT, Phiri MM, Vinikoor MJ, Masenga SK, Aliyu MH. Urine kidney injury molecule-1 predicts subclinical kidney disease among persons living with HIV initiating tenofovir disoproxil fumarate-based ART in Zambia. Front Nephrol. 2024; 4:1468409. PMID: 39834612.

  Read At: PubMed

• Published on 12/18/2024

  Zheng A, Kileel EM, Brennan AT, Flynn DB, Rosen S, Fox MP. Systematic Review and Meta-Analysis of Retention and Disengagement After Initiation on Antiretroviral Therapy in Low- and Middle-Income Countries After the Introduction of Universal Test and Treat Policies. medRxiv. 2024 Dec 18. PMID: 39763529.

  Read At: PubMed

View 102 more publications:View Full Profile at BUMC